Quick Overview: Opening Plenary: The Future of Cell & Gene How Do We as an Industry Support Rare & Ultra-Rare Disease? ATW Josh Ludwig - Global Commercial Director at ScaleReady talks to IBTV about G-Rex, open collaboration and ScaleReady's ...

Advanced Therapies Week 2025 Superplenary - Detailed Overview & Context

Opening Plenary: The Future of Cell & Gene How Do We as an Industry Support Rare & Ultra-Rare Disease? ATW Josh Ludwig - Global Commercial Director at ScaleReady talks to IBTV about G-Rex, open collaboration and ScaleReady's ... Decentralized Manufacturing & Point of Care ATW Chris White, Patient, Mucosal Melanoma & TIL Tile21 Health Solution's CEO Tony Pare talks to IBTV at Phacilitate's -

Stella Vnook - Founder and CEO of Likarda talks to IBTV at the ATW Awards GermFree's Stephen Ondek and Sean Bartholomew talk to IBTV at Phacilitate's - Ohad Karnieli, Founder and CEO at ADVA Biotechnology talks to IBTV at the ATW Awards

Photo Gallery

Advanced Therapies Week 2025: Superplenary
Advanced Therapies Week 2025 Highlights Video
Advanced Therapies Week 2025: Opening Plenary
Advanced Therapies Week 2025: Developing Advanced Therapies in Saudi Arabia
Jeff Wren & Priya Baraniak talk to IBTV at Advanced Therapies Week 2025
Advanced Therapies Week 2025: How Do We As An Industry Support Rare Ultra Rare Disease
Advanced Therapies Week 2025: Expanding the Scope of Gene Therapy
Josh Ludwig - Global Commercial Director at ScaleReady talks to IBTV at Advanced Therapies Week 2025
Advanced Therapies Week 2025: Decentralized Manufacturing and Point of Care
Advanced Therapies Week 2025 Trailer
Chris White, Patient & TIL therapy recipient talks to IBTV at Advanced Therapies Week 2025
Tile21's CEO Tony Pare talks to IBTV at Advanced Therapies Week 2025
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored